Gynica And Lumir Labs Partner Up To Find Marijuana-Based Endometriosis Treatment

Gynica, a company that focuses on clinically proven cannabis-based solutions in the field of women's health, developing optimal therapeutic results based on innovative technology and understanding of the pharmacological effects of different cannabinoids and compounds, targeted to specific female-related diseases, is collaborating with Lumir Lab, a research and development lab focused on cannabinoids, to find a cannabis-based treatment for endometriosis.

Who Is Gynica?

The Gynica team is led by the President of the European Association of Perinatal Medicine, Professor Moshe Hod, who is also a Tel Aviv University medical school professor of obstetrics and gynecology.

Commenting on the partnership, Yotam Hod, CEO and co-founder of Gynica told Benzinga that both his company and Lumir Lab are committed to discovering cannabis-based solutions to treat endometriosis and “finally put an end to the pain experienced by more than 176 million women worldwide.

“Specializing in R&D, quality control, and the development of custom formulations and delivery methods, we continue to explore and discover pioneering advancements in medical cannabis. We are dedicated to scientific research that leads to an improved quality of life, as we continue discovering, developing, and providing the leading innovations and solutions of the future.” 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechCannabisNewsMarketsGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.